Lasitha Senadheera1, Dirk Mayer2, 3, Sonal Josan2, 3, Yi-Fen Yen4, Moses Darpolor3, Jae Mo Park3, Ralph E. Hurd4, Richard Luong5, Lei Xing1, Daniel M. Spielman3
1Radiation Oncology, Stanford University, Stanford, CA, United States; 2Neuroscience Program, SRI International, Menlo Park, CA, United States; 3Radiology, Stanford University, Stanford, CA, United States; 4Global Applied Science Laboratory, GE Healthcare, Menlo Park, CA, United States; 5Comparative Medicine, Stanford University, Stanford, CA, United States
Radiation-induced metabolic response of TRAMP prostate tumor was investigated with 13C MRSI of hyperpolarized [1-13C]Pyruvate. The pyruvate metabolism in the tumors of two groups of mice, x-ray treated and untreated, was assessed in terms of Lactate/Pyruvate ratio. The Lactate/Pyruvate ratio was uncorrelated with the tumor size but was significantly (P < 0.05) lower in the treated group than the untreated. Our preliminary data suggest the feasibility of using 13C MRSI for detecting therapeutic response of prostate cancer to radiation in TRAMP mice.
Keywords